PHARMAZEUTISCHE ZUSAMMENSETZUNG ZUR APPETITZÜGELUNG MIT N2-(M-TRIFLUORBENZYL), (N6-P-NITROBENZYL)PURIN (TNP) ODER EINEM PHARMAZEUTISCH AKZEPTABLEN SALZ DARAUS ALS WIRKSTOFF

Abstract

The present invention relates to a pharmaceutical composition containing TNP (N2-(m-Trifluorobenzyl), N6-(p-nitrobenzyl)purine) or a pharmaceutically acceptable salt thereof as an active ingredient for suppressing appetite. Particularly, TNP or a pharmaceutically acceptable salt thereof can be effectively used as an active ingredient of a pharmaceutical composition or a nutraceutical food for suppressing appetite since it is confirmed that food intake is reduced and weight gain is inhibited in mice when the central nervous system of mice is treated with TNP.